Scholarlink

Background <p>The association between maternal cervical Ureaplasma urealyticum (Uu) colonization and adverse perinatal outcomes remains controversial. This study aimed to investigate the relationship between maternal cervical Uu colonization, Uu load during mid-pregnancy, and perinatal outcomes, with a focus on complications in preterm infants.</p> Methods <p>This prospective multicenter cohort study was conducted between July 2021 and January 2024 at four tertiary-level maternity and children’s hospitals in Zhejiang Province, China. Pregnant women with ultrasound-confirmed gestational age of 20<sup>+ 0</sup> to 24<sup>+ 6</sup> weeks were enrolled, and cervical Uu colonization was assessed by polymerase chain reaction (PCR). Pregnancy outcomes, including spontaneous preterm birth, pregnancy loss, and neonatal complications, were systematically recorded and analyzed.</p> Results <p>Among 452 enrolled participants in this prospective multicenter study, 243 (42.5%) tested positive for Uu colonization. The median Uu DNA load among Uu-positive pregnant women was 1.46 × 10<sup>5</sup>copies/ml. The rate of discontinuation of life-sustaining therapy among preterm infants born at 23–25 weeks of gestation was significantly higher in the Uu-positive group compared to the Uu-negative group (3.7% vs. 0.5%, <i>P</i> = 0.045). Women with high Uu load (≥ 10⁵ copies/mL) had significantly increased rates of spontaneous preterm birth before 32 weeks, spontaneous preterm birth before 28 weeks, premature rupture of membranes (PROM), and neonatal death, compared to those with low or no colonization (<i>P</i> &lt; 0.05). Multivariate analysis identified Uu load ≥ 10⁵ copies/mL as an independent risk factor for preterm birth before 32 weeks of gestation, with an OR of 5.653 (95%CI: 2.032 ~ 15.727).</p> Conclusions <p>Maternal cervical Uu load ≥10⁵ copies/mL may be associated with increased risk of spontaneous preterm birth before 32 weeks.</p> Trial registration <p>The research protocol was registered in the Chinese Clinical Trial Registry (No. ChiCTR2100044524) on 10 March 2021.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association between maternal cervical Ureaplasma urealyticum colonization and adverse perinatal outcomes: a prospective multicenter cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月26日

查看全文
  • Cuie Chen,
  • Shuangkui Zhao,
  • Jianmiao Hu,
  • Xianhu Fu,
  • Shujun Chen,
  • Jiajun Zhu,
  • Liping Shi,
  • Danqing Chen,
  • Yanping Xu

摘要

Background

The association between maternal cervical Ureaplasma urealyticum (Uu) colonization and adverse perinatal outcomes remains controversial. This study aimed to investigate the relationship between maternal cervical Uu colonization, Uu load during mid-pregnancy, and perinatal outcomes, with a focus on complications in preterm infants.

Methods

This prospective multicenter cohort study was conducted between July 2021 and January 2024 at four tertiary-level maternity and children’s hospitals in Zhejiang Province, China. Pregnant women with ultrasound-confirmed gestational age of 20+ 0 to 24+ 6 weeks were enrolled, and cervical Uu colonization was assessed by polymerase chain reaction (PCR). Pregnancy outcomes, including spontaneous preterm birth, pregnancy loss, and neonatal complications, were systematically recorded and analyzed.

Results

Among 452 enrolled participants in this prospective multicenter study, 243 (42.5%) tested positive for Uu colonization. The median Uu DNA load among Uu-positive pregnant women was 1.46 × 105copies/ml. The rate of discontinuation of life-sustaining therapy among preterm infants born at 23–25 weeks of gestation was significantly higher in the Uu-positive group compared to the Uu-negative group (3.7% vs. 0.5%, P = 0.045). Women with high Uu load (≥ 10⁵ copies/mL) had significantly increased rates of spontaneous preterm birth before 32 weeks, spontaneous preterm birth before 28 weeks, premature rupture of membranes (PROM), and neonatal death, compared to those with low or no colonization (P < 0.05). Multivariate analysis identified Uu load ≥ 10⁵ copies/mL as an independent risk factor for preterm birth before 32 weeks of gestation, with an OR of 5.653 (95%CI: 2.032 ~ 15.727).

Conclusions

Maternal cervical Uu load ≥10⁵ copies/mL may be associated with increased risk of spontaneous preterm birth before 32 weeks.

Trial registration

The research protocol was registered in the Chinese Clinical Trial Registry (No. ChiCTR2100044524) on 10 March 2021.